X |
Filing Date |
Trade Date |
Ticker |
Company Name | Industry | Ins |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 M | 2026-08-11 | LTC | Ltc Properties Inc | Real Estate Investment Trusts | 2 | P - Purchase | $36.36 | +18,000 | 94,230 | +24% | +$654,540 | |||||
| 5 | 2026-08-11 | XRN | Chiron Real Estate Inc. | Real Estate Investment Trusts | 3 | P - Purchase | $36.05 | +69,975 | 230,996 | +43% | +$2,522,709 | |||||
| 11 DM | 2026-06-26 | LILA | Liberty Latin America Ltd. | Cable & Other Pay Television Services | 6 | P - Purchase | $9.01 | +16,078,413 | 36,236,042 | +80% | +$144,890,860 | |||||
| 6 | 2026-08-12 | CC | Chemours Co | Chemicals & Allied Products | 6 | P - Purchase | $15.49 | +29,603 | 726,721 | +4% | +$458,620 | |||||
| 5 | 2026-08-11 | KMPR | Kemper Corp | Fire, Marine & Casualty Insurance | 5 | P - Purchase | $26.28 | +14,000 | 239,000 | +6% | +$367,880 | |||||
| 3 | 2026-08-11 | HOG | Harley-Davidson, Inc. | Motorcycles, Bicycles & Parts | 3 | P - Purchase | $25.03 | +57,500 | 80,105 | +254% | +$1,439,491 | |||||
| 3 D | 2026-08-07 | ELAN | Elanco Animal Health Inc | Pharmaceutical Preparations | 3 | P - Purchase | $23.07 | +19,200 | 380,654 | +5% | +$442,876 | |||||
| 2 | 2026-08-11 | CE | Celanese Corp | Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) | 2 | P - Purchase | $45.54 | +2,753 | 63,048 | +5% | +$125,364 | |||||
| 9 M | 2026-08-11 | AMRZ | Amrize Ltd | Cement, Hydraulic | 7 | P - Purchase | $48.47 | +44,329 | 2,382,449 | +2% | +$2,148,596 | |||||
| 4 | 2026-08-12 | EMBC | Embecta Corp. | Surgical & Medical Instruments & Apparatus | 4 | P - Purchase | $4.85 | +115,000 | 1,486,560 | +8% | +$557,945 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-08-12 | MTDR | Matador Resources Co | Foran Joseph Wm | COB, CEO | P - Purchase | $51.92 | +15,000 | 5,479,275 | 0% | +$778,800 | |||||
2026-08-13 | BORR | Borr Drilling Ltd | Currie Jeffrey | Dir | P - Purchase | $4.01 | +125,000 | 479,423 | +35% | +$501,638 | ||||||
2026-08-12 | GLXY | Galaxy Digital Inc. | Deason Douglas R | Dir | P - Purchase | $21.54 | +12,000 | 102,348 | +13% | +$258,432 | ||||||
| DM | 2026-08-05 | ATTO | Attovia Therapeutics, Inc. | Walsh Colin | Dir | P - Purchase | $17.58 | +585,000 | 3,020,632 | +24% | +$10,285,000 | |||||
| DM | 2026-08-05 | ATTO | Attovia Therapeutics, Inc. | Goldman Sachs Group Inc | Former 10% Owner | P - Purchase | $17.58 | +585,000 | 3,020,632 | +24% | +$10,285,000 | |||||
2026-08-13 | OPFI | Oppfi Inc. | Schwartz Todd G. | CEO, 10% | P - Purchase | $7.13 | +60,000 | 27,460,835 | 0% | +$427,680 | ||||||
| M | 2026-08-12 | TXO | Txo Partners, L.P. | Simpson Bob R | Dir, 10% | P - Purchase | $14.34 | +150,000 | 9,500,000 | +2% | +$2,150,545 | |||||
2026-08-13 | CVRX | Cvrx, Inc. | Binkowski Brent | COO | P - Purchase | $2.91 | +26,223 | 56,514 | +87% | +$76,432 | ||||||
| M | 2026-08-11 | LTC | Ltc Properties Inc | Gruber David L | Dir | P - Purchase | $38.30 | +4,000 | 48,070 | +9% | +$153,200 | |||||
2026-08-11 | XRN | Chiron Real Estate Inc. | Decker Mark Okey Jr | CEO, Pres | P - Purchase | $35.92 | +6,875 | 78,603 | +10% | +$246,950 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-08-13 | BORR | Borr Drilling Ltd | Currie Jeffrey | Dir | P - Purchase | $4.01 | +125,000 | 479,423 | +35% | +$501,638 | ||||||
2026-08-13 | CVRX | Cvrx, Inc. | Binkowski Brent | COO | P - Purchase | $2.91 | +26,223 | 56,514 | +87% | +$76,432 | ||||||
2026-08-13 | ALT | Altimmune, Inc. | Durso Jerome Benedict | Pres, CEO | P - Purchase | $2.95 | +15,000 | 62,500 | +32% | +$44,250 | ||||||
2026-08-12 | EMBC | Embecta Corp. | Kurdikar Devdatt | Pres, CEO | P - Purchase | $4.70 | +30,000 | 804,919 | +4% | +$140,937 | ||||||
2026-08-12 | EMBC | Embecta Corp. | Elguicze Jacob | SVP, CFO | P - Purchase | $4.67 | +20,000 | 309,139 | +7% | +$93,360 | ||||||
2026-08-12 | EMBC | Embecta Corp. | Mann Jeffrey Z | Pres, Pharm Svc, Prod Mgmt, CL | P - Purchase | $4.99 | +20,000 | 262,915 | +8% | +$99,800 | ||||||
2026-08-12 | EMBC | Embecta Corp. | Hombach Robert J. | Dir | P - Purchase | $4.97 | +45,000 | 109,587 | +70% | +$223,848 | ||||||
| D | 2026-08-11 | EVGN | Evogene Ltd. | Recanati Leon | Dir | P - Purchase | $0.64 | +460,000 | 1,343,886 | +52% | +$292,100 | |||||
| D | 2026-08-03 | HEPA | Hepion Pharmaceuticals, Inc. | Stetz Gary S. II | Dir | P - Purchase | $0.05 | +500,000 | 500,000 | New | +$25,000 | |||||
| D | 2026-08-03 | HEPA | Hepion Pharmaceuticals, Inc. | Stetz Gary S. | Interim CEO | P - Purchase | $0.05 | +2,000,000 | 3,250,000 | +160% | +$100,000 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-08-12 | SMFG | Sumitomo Mitsui Financial Group, Inc. | Anchi Kazuyuki | Sr. Mg. Corp. EO, Group CFO | S - Sale | $42.47 | -4,000 | 48,857 | -8% | -$169,880 | ||||||
| D | 2026-08-05 | ATTO | Attovia Therapeutics, Inc. | Walsh Colin | Dir | S - Sale+OE | $21.28 | -105,807 | 3,020,632 | -3% | -$2,251,658 | |||||
| D | 2026-08-05 | ATTO | Attovia Therapeutics, Inc. | Goldman Sachs Group Inc | Former 10% Owner | S - Sale+OE | $21.28 | -105,807 | 3,020,632 | -3% | -$2,251,658 | |||||
2026-08-11 | SKYH | Sky Harbour Group Corp | Boston Omaha Corp | 10% | S - Sale | $10.00 | -360,000 | 10,979,994 | -3% | -$3,600,000 | ||||||
| D | 2026-08-11 | ONC | Beone Medicines Ltd. | Lee Chan Henry | SVP, GC | S - Sale+OE | $360.00 | -2,666 | 325,312 | -1% | -$959,760 | |||||
| D | 2026-08-11 | PCOR | Procore Technologies, Inc. | Fleming William Fred Jr | SVP, Corporate Controller | S - Sale+OE | $58.95 | -10,000 | 104,981 | -9% | -$589,500 | |||||
2026-08-12 | SCHW | Schwab Charles Corp | Schwab Charles R. | Co-COB | S - Sale | $108.18 | -46,410 | 94,466,076 | 0% | -$5,020,448 | ||||||
| DM | 2026-08-11 | ARQT | Arcutis Biotherapeutics, Inc. | Burnett Patrick | See Remarks | S - Sale+OE | $26.33 | -15,000 | 119,289 | -11% | -$394,897 | |||||
| D | 2026-08-11 | TXRH | Texas Roadhouse, Inc. | Moore Gregory N | Dir | S - Sale+OE | $208.32 | -3,000 | 26,900 | -10% | -$624,960 | |||||
| D | 2026-08-11 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $179.74 | -60,000 | 72,588 | -45% | -$10,784,659 |
X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-08-12 | MTDR | Matador Resources Co | Foran Joseph Wm | COB, CEO | P - Purchase | $51.92 | +15,000 | 5,479,275 | 0% | +$778,800 | |||||
2026-08-13 | BORR | Borr Drilling Ltd | Currie Jeffrey | Dir | P - Purchase | $4.01 | +125,000 | 479,423 | +35% | +$501,638 | ||||||
2026-08-12 | GLXY | Galaxy Digital Inc. | Deason Douglas R | Dir | P - Purchase | $21.54 | +12,000 | 102,348 | +13% | +$258,432 | ||||||
2026-08-12 | BLTE | Belite Bio, Inc | Chuang Hao-Yuan | CFO | S - Sale | $180.35 | -367 | 93,433 | 0% | -$66,187 | ||||||
2026-08-12 | BLTE | Belite Bio, Inc | Lin Yu-Hsin | CEO | S - Sale | $180.35 | -365 | 170,569 | 0% | -$65,827 | ||||||
2026-08-12 | SMFG | Sumitomo Mitsui Financial Group, Inc. | Anchi Kazuyuki | Sr. Mg. Corp. EO, Group CFO | S - Sale | $42.47 | -4,000 | 48,857 | -8% | -$169,880 | ||||||
| M | 2026-08-11 | YQ | 17 Education & Technology Group Inc. | Liu Chang | CEO, 10% | L - Small Acquisition | $2.44 | 3,324 | 71,301 | -4% | $8,122 | |||||
2026-08-13 | YQ | 17 Education & Technology Group Inc. | Liu Chang | CEO, 10% | P - Purchase | $2.41 | +853 | 71,301 | +1% | +$2,054 | ||||||
| DM | 2026-08-05 | ATTO | Attovia Therapeutics, Inc. | Walsh Colin | Dir | P - Purchase | $17.58 | +585,000 | 3,020,632 | +24% | +$10,285,000 | |||||
| D | 2026-08-05 | ATTO | Attovia Therapeutics, Inc. | Walsh Colin | Dir | S - Sale+OE | $21.28 | -105,807 | 3,020,632 | -3% | -$2,251,658 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |